Holen Sie sich die Stockscreener-App
10.16
7.13%
-0.78
Handel nachbörslich:
10.55
0.39
+3.84%
Schlusskurs vom Vortag:
$10.94
Offen:
$10.82
24-Stunden-Volumen:
590.61K
Relative Volume:
2.37
Marktkapitalisierung:
$514.13M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-83.74M
KGV:
-6.3106
EPS:
-1.61
Netto-Cashflow:
$-64.98M
1W Leistung:
-9.37%
1M Leistung:
-18.00%
6M Leistung:
-52.63%
1J Leistung:
-48.35%
1-Tages-Spanne:
$10.03
$11.79
1-Wochen-Bereich:
$10.03
$11.79
52-Wochen-Spanne:
$10.03
$29.60
Tyra Biosciences Inc Stock (TYRA) Company Profile
Firmenname
Tyra Biosciences Inc
Sektor
Branche
Telefon
(619) 728-4760
Adresse
2656 STATE STREET, CARLSBAD
Vergleichen Sie TYRA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TYRA
Tyra Biosciences Inc
|
10.16 | 514.13M | 0 | -83.74M | -64.98M | -1.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.01 | 128.40B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
744.83 | 81.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
571.00 | 34.69B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
233.07 | 30.17B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beone Medicines Ltd Adr
|
242.66 | 26.02B | 3.32B | -860.46M | -1.04B | -8.32 |
Tyra Biosciences Inc Stock (TYRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-07 | Eingeleitet | UBS | Buy |
| 2024-10-18 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-08-15 | Eingeleitet | Piper Sandler | Overweight |
| 2023-12-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-06-30 | Eingeleitet | Wedbush | Outperform |
| 2023-02-03 | Eingeleitet | Oppenheimer | Outperform |
| 2022-06-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-03-08 | Hochstufung | Jefferies | Hold → Buy |
| 2021-11-08 | Herabstufung | Jefferies | Buy → Hold |
| 2021-10-11 | Eingeleitet | BofA Securities | Buy |
| 2021-10-11 | Eingeleitet | Cowen | Outperform |
| 2021-10-11 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Tyra Biosciences Inc Aktie (TYRA) Neueste Nachrichten
Tyra Biosciences stock hits 52-week low at $10.62 amid market challenges - Investing.com Australia
Tyra Biosciences stock hits 52-week low at $10.62 amid market challenges By Investing.com - Investing.com South Africa
Rhumbline Advisers Grows Stake in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World
BALVERSA Adoption on the Rise: Meeting Unmet Needs in Advanced Urothelial Cancer | DelveInsight - GlobeNewswire Inc.
Tyra Biosciences, Inc. (NASDAQ:TYRA) Sees Large Growth in Short Interest - Defense World
Advanced Urothelial Carcinoma Clinical Trial Pipeline - GlobeNewswire
Non-Muscle Invasive Bladder Cancer Clinical and Non-Clinical - openPR
(TYRA) Investment Report - Stock Traders Daily
Tyra Biosciences: FGFR1/2 Driven AE Data Spooked The Market - Seeking Alpha
Brokerages Set Tyra Biosciences, Inc. (NASDAQ:TYRA) Price Target at $30.50 - Defense World
Tyra Biosciences (NASDAQ:TYRA) Hits New 12-Month LowTime to Sell? - MarketBeat
Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives $30.50 Consensus Target Price from Analysts - MarketBeat
Tyra Biosciences stock hits 52-week low at $11.88 amid market shifts - Investing.com Canada
(TYRA) Investment Analysis - Stock Traders Daily
Tyra Biosciences Inc (TYRA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire
TYRA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Tyra Biosciences Inc and Encourages Investors to Contact the Firm Today! - ACCESS Newswire
Tyra Biosciences' (TYRA) Buy Rating Reiterated at HC Wainwright - MarketBeat
Tyra Biosciences (NASDAQ:TYRA) Given “Buy” Rating at HC Wainwright - Defense World
Tyra Biosciences (NASDAQ:TYRA) Stock Price Up 6.6%Here's What Happened - MarketBeat
Tyra Biosciences director Nina Kjellson sells $78,466 in stock - MSN
Tyra Biosciences director Nina Kjellson sells $74,323 in stock - MSN
Tyra Biosciences (NASDAQ:TYRA) Reaches New 52-Week LowShould You Sell? - MarketBeat
Nina S. Kjellson Sells 5,401 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) Stock - MarketBeat
Exclusive: Tyra Biosciences Sets Ambitious 4-Conference Roadshow Including Prestigious Biotech on the Beach - StockTitan
Tyra Biosciences (NASDAQ:TYRA) Sets New 1-Year LowHere's What Happened - MarketBeat
An Analysis of Tyra Biosciences Inc (TYRA)’s Potential Price Growth - Knox Daily
Financial Fitness Check: Examining Tyra Biosciences Inc (TYRA)’s Key Ratios - The Dwinnex
How to Take Advantage of moves in (TYRA) - Stock Traders Daily
Tyra Biosciences (NASDAQ:TYRA) Reaches New 12-Month Low – Here’s What Happened - Armenian Reporter
Tyra Biosciences director Nina Kjellson sells $74,323 in stock By Investing.com - Investing.com Australia
TYRA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Tyra Biosciences Inc and Encourages Shareholders to Contact the Firm! - ACCESS Newswire
Director’s Stock Sale Unveils Major Moves at Tyra Bioscience! - TipRanks
Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives $30.50 Average Price Target from Analysts - MarketBeat
Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives $30.50 Consensus PT from Analysts - Defense World
Tyra Biosciences adds Adele Gulfo to board - MSN
Tyra Biosciences appoints new board member - MSN
Tyra Biosciences appoints new board member By Investing.com - Investing.com Australia
Tyra Biosciences Insider Ups Holding By 284% During Year - Simply Wall St
TYRA INVESTIGATION NOTICE: Kaskela Law LLC Announces Investigation of Tyra Biosciences, Inc. (TYRA) and Encourages Investors to Contact the Firm - ACCESS Newswire
Tyra Biosciences adds Adele Gulfo to board By Investing.com - Investing.com South Africa
Tyra Biosciences Announces Appointment of Adele Gulfo to Board of Directors - PR Newswire
Finanzdaten der Tyra Biosciences Inc-Aktie (TYRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.98%
8.97%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):